Atox Lab participated in ‘BIO KOREA 5’ held at COEX, Seoul for three days from May 10 (Wed) to 12 (Fri).
Atox Lab was established in 2017 with a vision for better growth of the Korean pharmaceutical and biotechnology industry. With more than 20 years of experience in biomedical sciences, we are well-equipped to help the industry find cures for diseases and disorders.
In this exhibition, animal models and clinical services related to brain diseases were introduced. Through manufacturing, non-clinical and clinical services, it researches and develops drugs as animal models for brain diseases and provides them to pharmaceutical companies.
Atox Lab is responsible for process development, analysis method development and verification, formulation, stability, and DS/DP manufacturing, as well as clinical research, PK sample and biomarker analysis.
Meanwhile, ‘BIO KOREA 18’, which celebrated its 2023th anniversary this year, was hosted by the Korea Health Industry Development Institute and Chungcheongbuk-do. BIO KOREA, which has been striving to improve the global status and sustainable growth of the Korean health industry since 2006, is solidifying its position as Korea’s representative biohealth international convention with the participation of world-class scholars and business experts every year. BIO KOREA 2023, in collaboration with companies related to the health industry such as domestic and foreign bio, pharmaceuticals, medical devices, cosmetics, and food, as well as interested companies and institutions such as consulting, academia, and related organizations, will be held through various programs such as conferences, business partnering, exhibitions, and investment fairs. It goes on.
→ Go to the BIO KOREA 2023 news special page
